Jong Wook Chang

USPTO Granted Patents = 10 (Patent Applications = 11)

CIPO Patents = 5

EPO Patents = 6 (Patent Applications = 13)

Average Co-Inventor Count = 3.5

ph-index = 1

Forward Citations = 6(Granted Patents)

Company Filing History:

Samsung Life Public Welfare Foundation

where one patent can have more than one assignee

Years Active: 2013-2025

Loading Chart...

10 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12491233 - Pharmaceutical composition, for preventing or treating Charcot-Marie-Tooth disorder, comprising mesenchymal stem cells or insulin secreted by mesenchymal stem cells (2025-12-09),

2. 12433935 - Producing method of mesenchymal stem cell for prevention or treatment of brain neuronal disease including ghrelin treatment and use thereof (2025-10-07),

3. 12195760 - Method for enhancing proliferation capability of stem cells using ethionamide (2025-01-14),

4. 11946070 - Method of reinforcing efficacy of stem cells using ethionamide (2024-04-02),

5. 11913020 - Method for improving stem cell migration using ethionamide (2024-02-27),

6. 10238692 - Composition comprising a culture solution of mesenchymal stem cells for the treatment of neural diseases (2019-03-26),

7. 9439931 - Administering umbilical cord blood-derived mesenchymal stem cells to treat nerve injury (2016-09-13),

8. 9387226 - Neural cell proliferation induced through the culture of neural cells with umbilical cord blood-derived mesenchymal stem cells (2016-07-12),

9. 8614191 - Use of ICAM-1 for prevention or treatment of neurological diseases (2013-12-24),

10. 8506948 - UCB-MSCs comprising a tumor suppressor gene reduce the size of an IL-8 or GRO-αexpressing tumor (2013-08-13),

Title: Jong Wook Chang: Innovator in Stem Cell Research

Introduction

Jong Wook Chang is a prominent inventor based in Seoul, South Korea. He has made significant contributions to the field of stem cell research, holding a total of 10 patents. His work focuses on innovative methods for producing mesenchymal stem cells, which have potential applications in treating various brain neuronal diseases.

Latest Patents

Chang's latest patents include a groundbreaking method for producing mesenchymal stem cells aimed at preventing or treating brain neuronal diseases, including the use of ghrelin. This method not only outlines the production of these stem cells but also details a pharmaceutical composition that can effectively address conditions such as Alzheimer's disease. Another notable patent involves a medium composition that enhances the proliferation capability of stem cells using ethionamide. This method allows for the mass production of highly efficient next-generation stem cells without the need for genetic modification or viral vectors.

Career Highlights

Throughout his career, Jong Wook Chang has worked with notable organizations such as Medipost Co., Ltd and the Samsung Life Public Welfare Foundation. His innovative approaches and research have positioned him as a leader in the field of stem cell technology.

Collaborations

Chang has collaborated with esteemed colleagues, including Yoon-Sun Yang and Duk Lyul Na, contributing to the advancement of stem cell research and its applications.

Conclusion

Jong Wook Chang's contributions to stem cell research and his innovative patents highlight his role as a key figure in the scientific community. His work continues to pave the way for new treatments for brain neuronal diseases, showcasing the potential of stem cell technology.

This text is generated by artificial intelligence and may not be accurate.